Related Experiment Video
Updated: Mar 23, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Combined Population Dynamics and Entropy Modelling Supports Patient Stratification in Chronic Myeloid Leukemia
Marc Brehme1, Steffen Koschmieder2, Maryam Montazeri1
1Joint Research Center for Computational Biomedicine (JRC-COMBINE), RWTH Aachen University, 52062 Aachen, Germany.
This study models cancer progression using chronic myeloid leukemia (CML) as a guide. Combined genomic analysis and dynamic modeling stratify patients with high resolution, improving personalized risk assessment.
Area of Science:
- Oncology
- Computational Biology
- Genomics
Background:
- Multistep carcinogenesis modeling is crucial for understanding cancer progression and developing targeted therapies.
- Chronic myeloid leukemia (CML) serves as a model for hierarchical disease evolution.
- Accurate patient stratification is essential for personalized cancer treatment.
Purpose of the Study:
- To develop a novel approach for patient stratification in CML using population dynamic modeling and genomic analysis.
- To identify new biomarkers for disease progression and heterogeneity within CML stages.
- To enable quantitative approximation of individual patient disease history and risk assessment.
Main Methods:
- Combined population dynamic modeling with genomic analysis of CML patient biopsies.
- Utilized CD34(+) similarity as a disease progression marker.
- Applied patient-derived gene expression entropy analysis.
Main Results:
- Achieved unprecedented patient stratification resolution in CML.
- Linked CD34(+) similarity and gene expression entropy to separate CML progression stages.
- Uncovered significant heterogeneity within established CML disease stages.
- Developed a model that quantitatively approximates individual patient disease history in chronic phase (CP), distinguishing early from late CP.
Conclusions:
- The developed model offers a novel, genome-informed approach for personalized risk assessment in CML.
- This method is independent and complementary to existing measures of CML disease burden and prognosis.
- Findings pave the way for more precise and individualized CML management strategies.
More Related Videos
06:33Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Differentiation of Common Myeloid Progenitor Cells
Mechanistic Models: Compartment Models in Individual and Population Analysis